Actually, let me reframe that
But if we do some quick calculations, if everyone who was obese in the US went on Wegovy, someone would have to foot a bill of $3 trillion per year
GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging
Town & Country, based in Ramsey, New Jersey, was charging patients about $200 a month about one-fifth the list price for Zepbound and less than half the price Lilly charges self-paying patients
Many people begin noticing differences in appetite and cravings within a few weeks